Module 1
Short- and long-term public health interventions to promote refugee and migrant health
Tool 1: Main communicable diseases
Tool overview
While there are a number of communicable diseases that impact populations, especially refugee and migrant populations, this tool will focus on the main communicable diseases that contribute to morbidity and mortality.
Tuberculosis, HIV and Malaria
Tuberculosis, HIV and Malaria continue to take a disproportionally large toll on the poorest, least-educated and most rural parts of society. Certain communities face stigma and discrimination, resulting in lower service access and higher disease risk; these communities include sexual and gender minorities, sex workers, people in prisons, people who inject drugs, refugees, migrants, displaced people and indigenous people. The COVID-19 pandemic has further exposed these fault lines.
Tuberculosis
TB is a disease of poverty and is associated with precarious living conditions, overcrowding, food and job insecurity, and weak health systems. Vulnerability to TB is increased by nutritional status, HIV status, housing conditions, working conditions, access to health services and lifestyle factors such as the use of alcohol, tobacco and other substances. TB claims more lives than any other infectious disease. It exists in all countries and age groups but disproportionally affects populations in low- and middle-income countries and people living in poverty. Key populations for TB response may include people in prison and other closed settings, people living with HIV, refugees, migrants and indigenous populations. They experience an increased impact from the disease and have higher risks of infection due to structural, environmental, biological and behavioural factors; they may also experience barriers to services stemming from criminalization, stigma and discrimination.
HIV
In 2016 the World Health Assembly endorsed the development of the updated Global Health Sector Strategy on HIV 2016–2021. This strategy established the role of the health sector in responding to HIV, including delivering for equity, by adapting HIV services for different populations and locations. The subsequent UNAIDS Global AIDS Strategy 2021–2026 specified high-level targets and commitments for 2025. These priorities focus on maximizing equitable and equal access to HIV services, eliminating barriers to achieving HIV outcomes and fully resourcing and sustaining HIV responses. Key populations in the HIV response include men who have sex with men, transgender people (especially transgender women), people who inject drugs, sex workers and people in prison and detention. Migrants and mobile populations are at a higher risk for HIV infection, especially women, who are more likely to be adversely affected by mobility issues than men.
Malaria
The WHO Global Technical Strategy for Malaria 2016–2030 provides guidance for the control and elimination of malaria, citing equity as a central principle. People who are socioeconomically disadvantaged (poor, low levels of education, poorly constructed homes, work in agriculture, etc.) have a higher risk of malaria infection. Underserved populations in the malaria response may include refugees, migrants, internally displaced people and indigenous populations. These populations are underserved because they have been traditionally excluded from disease control efforts and tend to have compromised access to health and malaria prevention efforts and control services. In some settings, for example, they may not be meaningfully considered by the laws, policies and legal frameworks that facilitate access to health and malaria services.
Disease outbreaks, epidemic and pandemics
Disease outbreaks, epidemics and pandemics have become more frequent as new pathogens continue to emerge with potential to cause large-scale morbidity and mortality and the ability to move around the world has increased. Recently, the West African Ebola outbreak, severe acute respiratory syndrome (SARS) and SARS-CoV-2 have had major impacts on national economies, affecting health, travel, trade and all aspects of life. The COVID-19 pandemic caused by SARS CoV-2 has overwhelmed many health systems and affected the delivery of essential health care. In addition to the morbidity and mortality related to COVID-19, there has also been a rise in health issues, morbidity and mortality linked to other diseases. The International Health Regulations 2005 (IHR) obligates States to develop and maintain national core capacities for the detection, investigation, response and reporting of potential public health events of international concern within their territories. Following the review of the response to the Ebola outbreak, countries have strengthened capacities for IHR implementation and instituted voluntary joint external evaluations, a number of which have been undertaken. WHO's Joint Evaluation Tool looks at the four groups of capacities:
- prevention capacities cover national legislation, policy, financing, coordination, communication and advocacy as well as zoonotic disease, food safety, biosafety, biosecurity and immunization;
- detection capacities look at national laboratory systems, surveillance, reporting and human resources;
- response capacities assess emergency preparedness, emergency response operations, linking public health and security authorities, medical countermeasures and personnel deployment, and risk communication; and
- IHR-related hazards examine points of entry, chemical events and radiation emergencies.
Neglected tropical diseases
Neglected tropical diseases (NTDs) are a diverse group of tropical infections that are common in low-income populations in Africa, the Americas and Asia. There are four groups of tropical diseases categorized here:
- those likely to occur in emergency settings and refugee camps;
- those that should be monitored as associated with high morbidity or case-fatality rate
- those targeted for eradication, elimination or elimination as a public health problem; and
- those associated with disability, stigma and social exclusion.
Guidance and tools
Tuberculosis
Guidance, training, reports
Global tuberculosis report 2022
The WHO Global Tuberculosis Report 2022 provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis...
Tuberculosis prevention and care among refugees and other populations in humanitarian settings: an interagency...
Tuberculosis (TB) remains one of the leading infectious diseases causing millions to fall ill and lose their lives annually. Refugees and other populations...
WHO consolidated guidelines on tuberculosis: Module 1: Prevention - infection prevention and control
Infection prevention and control consists of evidence-based measures intended to prevent exposure and reduce the risk of transmission of infectious agents.The...
People-centred framework for tuberculosis programme planning and prioritization: user guide
Tuberculosis control in migrant populations : guiding principles and proposed actions
Tuberculosis control in complex emergencies
Tools
HIV/AIDS
Guidance, training, reports
Tools
Malaria
Guidance, training, reports
World malaria report 2022
Tools
Tuberculosis, HIV, Malaria
Guidance, training, reports
State of inequality: HIV, tuberculosis and malaria
Diarrhoeal diseases, cholera
Guidance, training, reports
Tools
Outbreaks, pandemics
Guidance, training, reports
Tools
WHO mass gathering COVID-19 risk assessment tool: generic events, version 3
WHO COVID-19 Essential Supplies Forecasting Tool (COVID-ESFT) v4.1
Building health systems resilience for universal health coverage and health security during the COVID-19 pandemic and beyond: WHO position paper
NTDs
Guidance, training, reports
Ending the neglect to attain the Sustainable Development Goals: A road map for neglected...
Additional resources